Abstract
Candidates to antitumor drugs of lipid nature are reviewed. The biological effects of the following known antineoplastic phosphate-containing lipids are described: edelfosine, ilmofosine, milfosine, perifosine, and erufosine. Although the most active phosphate-containing lipid edelfosine causes the death of tumor cells of different tissue origin, it possesses a strong hemolytic effect and toxicity toward non-malignant counterparts. The phosphate-containing lipids can be inactivated by phospholipases, which gave rise to the search for the optimum structure of cationic glycerolipids containing no phosphate group and having a similar antitumor activity. The results of structural functional studies of the non-phosphorus cationic glycerolipids with the best antitumor activity are generalized.
Similar content being viewed by others
References
S. M. Prescott, G. A. Zimmerman, D. M. Stafforini, T. M. McIntyre, Annu. Rev. Biochem., 2000, 69, 419.
F. Snyder, T. Ch. Lee, M. L. Blank, Annals of New York Academy of Sciences, 1989, 568, 35.
I. D. Konstantinova, G. A. Serebrennikova, Russ. Chem. Rev. (Engl.Transl.), 1996, 65, 537 [Usp. Khim., 1996, 65, 581].
I. D. Konstantinova, N. I. Zaitseva, I. P. Ushakova, G. A. Serebrennikova, Russ. Chem. Bull. (Int. Ed.), 1994, 43, 1731 [Izv. Akad. Nauk, Ser. Khim., 1994, 1826].
A. D. Miller, Angew. Chem. Int. Ed., 1998, 37, 1768.
D. D. Lasic, N. Templenton, Adv. Drug Del. Rev., 1996, 20, 221.
M. A. Maslov, E. V. Sycheva, N. G. Morozova, G. A. Serebrennikova, Russ. Chem. Bull. (Int. Ed.), 2000, 3, 385 [Izv. Akad. Nauk, Ser. Khim., 2000, 385].
D. Zhi, S. Zhang, B. Wang, Y. Zhao, B. Yang, S. Yu, Bioconjug. Chem., 2010, 10, 563.
T. Montier, T. Benvegnu, P. A. Jaffrès, J. J. Yaouanc, P. Lehn, Curr. Gene Ther., 2008, 8, 296.
B. M. Castro, A. Fedorov, V. Hornillos, J. Delgado, A. U. Acuca, F. Mollinedo, M. Prieto, J. Phys. Chem. B, 2013, 117, 7929.
T. Nieto-Miguel, R. Fonteriz, L. Vay, C. Gajate, S. Lopez-Hernandez, F. Mollinedo, Cancer Res., 2007, 67, 1368.
C. Gajate, F. Mollinedo, Curr. Drug Metab., 2002, 3, 491.
V. Patel, T. Lahusen, T. Sy, E. Sausville, J. Gutkind, A. Senderowicz, Cancer Res., 2002, 62, 1401.
C. Leethanakul, V. Patel, J. Gillespie, M. Pallente, J. F. Ensley, S. Koontongkaew, L. A. Liotta, M. Emmert-Buck, J. S. Gutkind, Oncogene, 2000, 19, 3220.
F. Mollinedo, C. Gajate, S. Martin-Santamarna, F. Gago, Curr. Medi. Chem., 2004, 11, 3163.
C. Gajate, F. Gonzalez-Camacho, F. Mollinedo, PLoS ONE, 2009, 4, 4.
B. Zheng, K. Oishi, K. Shoji, H. Eibl, W. E. Berdel, J. Wajdu, W. R. Vogler, J. F. Kuo, Cancer Res., 1990, 50, 3025.
K. Oishi, B. Zheng, J. F. White, W. R. Vogler, J. F. Kuo, Biochem. Biophys. Res. Commun., 1988, 157, 1000.
A. Girault, J. P. Haelters, M. Potier-Cartereau, A. Chantome, M. Pinault, S. Marionneau-Lambot, T. Oullier, G. Simon, H. Couthon-Gourvès, P. A. Jaffrès, B. Corbel, P. Bougnoux, V. Joulin, C. Vandier, Curr. Cancer Drug Targets, 2011, 11, 1111.
C. M. Lasenby, M. G. Thompson, J. A. Hickman, Cancer Res., 1990, 50, 3327.
C. J. Marasco, C. Piantadosi, K. L. Meyer, S. L. Morris-Natschke, K. S. Ishaq, G. W. Small, L. W. Daniel, J. Med. Chem., 1990, 33, 985.
E. W. Berdel, Br. J. Cancer, 1991, 64, 208.
M. Reis-Sobreiro, G. Roué, A. Moros, C. Gajate, J. de la Iglesia-Vicente, D. Colomer, F. Mollinedo, Blood Cancer J., 2013, 3, 118.
A. Naseer, B. Bok Hee, H. Jongki, L. Chong, S. Boo Ahn, I. Kwang Sik, H. Jee, J. Nat. Prod., 2001, 6, 533.
W. J. van Blitterswijk, M. Verheij, Biochim. Biophys. Acta, 2013, 1831, 663.
I. Ahmad, J. J. Filep, J. C. Franklin, A. S. Janoff, G. R. Masteers, J. Pattassery, A. Peters, J. J. Schupsky, Y. Zha, E. Mayhew, Cancer Res., 1997, 57, 1915.
J. Busto, Esther del Canto-Jacez, F. Goci, F. Mollinedo, A. Alonso, J. Chem. Biol., 2008, 1, 89.
E. Mayhew, I. Ahmad, S. Bhatia, R. Dause, J. Filep, A. S. Janoff, E. Kaisheva, W. R. Perkins, Y. Zha, J. C. Franklin, Biochim. Biophys. Acta., 1997, 1329, 139.
W. R. Perkins, R. B. Dause, X. Li, J. C. Franklin, D. J. Cabrall-Lilly, Y. Zha, E. H. Dank, E. Mayhew, A. S. Janoff, Biochim. Biophys. Acta, 1997, 1327, 61.
B. J. Giantonio, Ch. Derry, C. McAleer, J. J. McPhillips, P. J. O’Dwyer, Clin Cancer Res., 2004, 10, 1282.
R. Bittman, H. Byun, H. Chandraprakash Reddy, P. Samadder, H. Arthur, J. Med. Chem., 1997, 40, 1391.
P. G. Goekjian, M. R. Jirousek, Expert Opin Investig Drugs, 2001, 10, 2117.
R. I. Duclos, H. H. Chia, O. H. Abdelmageed, H. Esber, D. J. Fournier, A. Makriyannis, J. Med. Chem., 1994, 37, 41.
P. Principe, P. Braquet, Crit. Rev. Oncol. Hematol., 1995, 18, 155.
G. F. E. Scherer, B. Stoffel, Planta, 1987, 172, 127.
T. Sugiura, A. Yamashira, N. Kudo, T. Fukuda, T. Miyamoto, N. Chang, S. Kishimoto, K. Waku, T. Tanaka, H. Tsukatani, A. Tokumura, Biochim. Biophys. Acta., 1995, 1258, 19.
M. R. Temer, R. H. Lumb, Biochim. Biophys. Acta., 1989, 1004, 49.
S. Croft, D. Snowdon, V. Yardley, J. Antimicrob. Chemother., 1996, 38, 1041.
J. McBride, A. Mullen, K. Carter, C. Roberts, J. Antimicrobial Chemotherapy, 2007, 60, 521.
S. Vink, J. Schellens, W. Blitterswijk, M. Verheij, Investigational New Drug, 2005, 23, 279.
H. Lux, N. Heise, T. Klenner, D. Hart, F. R. Opperdoes, Molecular and Biocemical Parasitology, 2000, 111, 1.
S. Vink, W. Blitterswijk, J. Schellens, M. Verheij, Cancer Treatment Rev., 2007, 33, 191.
M. Fiegl, L. Lindner, M. Juergens, H. Eibl, W. Hiddemann, J. Braess, Cancer Chemother Pharmacol., 2008, 62, 321.
D. Yosifov, P. Todorov, M. Zaharieva, K. Georgiev, B. Pilicheva, S. Konstantinov, M. Berger, Cancer Chemother Pharmacol., 2010, 10, 1273.
P. Samadder, R. Bittman, H.-S. Byun, G. Arthur, J. Med. Chem., 2004, 47, 2710.
V. Jendrossek, R. Handrick, Curr. Med. Chem.-Anti-Cancer Agents, 2003, 3, 343.
N. V. Plyavnik, A. A. Shtil, G. A. Serebrennikova, Mini-Rev. Med. Chem., 2006, 6, 109.
F. Civoli, L. W. Daniel, Cancer Chemother. Pharmacol., 1998, 42, 319.
J. Hoffman, I. Utz, M. Spitaler, S. Hofer, M. Rybczynska, W. T. Beck, D. B. J. Herrmann, H. Grunicke, Br. J. Cancer, 1997, 76, 862.
S. L. Morris-Natschke, K. L. Meyer, C. J. Marasco, C. Piantadosi, F. Rossi, P. L. Godwin, E. J. Modest, J. Med. Chem., 1990, 33, 1812.
S. L. Morris-Natschke, F. Gumus, C. J. Marasco, K. L. Meyer, M. Marx, C. Piantadosi, M. D. Layne, E. J. Modest, J. Med. Chem., 1993, 36, 2018.
K. Ukawa, E. Imamiya, H. Yamamoto, T. Aono, Y. Kozai, T. Okutani, H. Nomura, Y. Honma, M. Hozumi, I. Kudo, K. Inoue, Chem. Pharm. Bull., 1989, 37, 3277.
N. V. Plyavnik, T. V. Kramareva, G. A. Serebrennikova, Bioorg. Chem., 2011, 37, 552 [Bioorg. Khim., 2011, 37, 552].
A. A. Markova, N. V. Plyavnik, M. V. Pletneva, G. A. Serebrennikova, A. A. Shtil, Klinicheskaya Onkogematologiya [Clinical Oncohematology], 2011, 5, 141 (in Russian).
A. A. Markova, N. V. Plyavnik, V. V. Tatarskii, A. A. Shtil, G. A. Serebrennikova, Bioorg. Chem., 2010, 36, 1.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 5, pp. 1081–1087, May, 2014.
Rights and permissions
About this article
Cite this article
Markova, A.A., Plyavnik, N.V., Morozova, N.G. et al. Antitumor phosphate-containing lipids and non-phosphorus alkyl cationic glycerolipids: chemical structures and perspectives of drug development. Russ Chem Bull 63, 1081–1087 (2014). https://doi.org/10.1007/s11172-014-0552-4
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11172-014-0552-4